Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03265964 · ClinicalTrials.gov registry record · Phase 4
Clinical and Imaging Trial of Uridine for Veterans With Suicidal Ideation
A Phase 4 study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- Phase 4
- Development phase
- 75
- Enrollment target
NCT03265964: Completed Phase 4 study, sponsored by VA Office of Research and Development.
NCT03265964 is a Phase 4 study that has completed, run by VA Office of Research and Development. The registered enrollment target is 75 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03265964, a Phase 4 study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 75 participants
- Enrollment target
Study Summary
This is a randomized, double-blind, placebo-controlled study of the investigational drug uridine as a treatment for suicidal ideation in veterans. The investigators hypothesize that the administration of a naturally occurring dietary supplement, uridine, will rapidly reduce suicidal ideation in veterans. The purpose of this study is to determine whether 4 weeks of uridine supplementation is an effective treatment for suicidal ideation in veterans, when compared to a group taking a placebo.
Interventions
- DRUG Placebo
- DRUG Uridine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2018-04-02 |
| Est. Completion | 2024-06-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03265964
The ClinicalTrials.gov registry entry for NCT03265964 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03265964 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03265964 about?
NCT03265964 is a clinical study titled "Clinical and Imaging Trial of Uridine for Veterans With Suicidal Ideation". This is a randomized, double-blind, placebo-controlled study of the investigational drug uridine as a treatment for suicidal ideation in veterans. The investigators hypothesize that the administration of a naturally occurring dietary supplement, uridine, will rapidly reduce suicidal ideation in vet...
What is the current status of trial NCT03265964?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 75 participants. The study started on 2018-04-02. Estimated completion is 2024-06-30.
What interventions are being tested in trial NCT03265964?
The interventions under investigation include: Placebo (DRUG), Uridine (DRUG).
Who is sponsoring clinical trial NCT03265964?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.